Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia

BACKGROUND: Cannabis-smoking patients with a psychotic disorder have poorer disease outcomes than non-cannabis-smoking patients with poorest outcomes in patients smoking high-potency cannabis (HPC) containing high Δ9-tetrahydrocannabinol (THC) and low cannabidiol (CBD). Quitting cannabis smoking or...

Descripción completa

Detalles Bibliográficos
Autores principales: van Amsterdam, Jan, Vervloet, Jojanneke, de Weert, Gerdien, Buwalda, Victor J. A., Goudriaan, Anna E., van den Brink, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149068/
https://www.ncbi.nlm.nih.gov/pubmed/30236118
http://dx.doi.org/10.1186/s12954-018-0253-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149068/
https://www.ncbi.nlm.nih.gov/pubmed/30236118
http://dx.doi.org/10.1186/s12954-018-0253-7

Ejemplares similares